Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-02-09 | Mr. Peter A. SmithPresident, CEO & Director | 9,30k | 102,30k | Derivative Exercise and Retained Stock | 11,00 | 358,75k | 2,66% |
| 2026-02-09 | Mr. Peter A. SmithPresident, CEO & Director | -17,09k | 261,87k | Derivative Exercise and Sale | 11,00 - 26,33 | 358,75k | - |
| 2026-02-06 | Mr. Gary G. CrokeSVP Product & Innovation | -6,91k | 131,19k | Derivative Exercise and Sale | 7,23 - 26,20 | 22,53k | - |
| 2025-11-11 | Mr. Bruce M. TatenIndependent Director | -3,27k | 76,44k | Vendita | 23,39 | 14,91k | -17,98% |
| 2025-11-11 | Mr. Peter A. SmithPresident, CEO & Director | -5,35k | 125,14k | Vendita | 23,39 | 349,45k | -1,51% |
| 2025-10-10 | Ms. Erin R. BoaseGeneral Counsel & VP of Legal Affairs | -847,00 | 17,82k | Sale to Issuer | 21,04 | 11,81k | -6,69% |
| 2025-10-10 | Mr. Andrew FredricksonVP of Corporate Finance | -214,00 | 4,50k | Sale to Issuer | 21,04 | 9,55k | -2,19% |
| 2025-10-10 | Mr. Gary G. CrokeSVP Product & Innovation | -786,00 | 16,54k | Sale to Issuer | 21,04 | 22,53k | -3,37% |
| 2025-10-10 | Mr. Peter A. SmithPresident, CEO & Director | -8,99k | 189,15k | Sale to Issuer | 21,04 | 354,80k | -2,47% |
| 2025-09-09 | Mr. Peter A. SmithPresident, CEO & Director | -78,00 | 1,81k | Sale to Issuer | 23,25 | 293,47k | -0,03% |
| 2025-09-01 | Mr. Gary G. CrokeSVP Product & Innovation | -504,00 | 11,57k | Sale to Issuer | 22,96 | 20,77k | -2,37% |
| 2025-09-01 | Ms. Erin R. BoaseGeneral Counsel & VP of Legal Affairs | -694,00 | 15,93k | Sale to Issuer | 22,96 | 8,47k | -7,57% |
| 2025-09-01 | Mr. Peter A. SmithPresident, CEO & Director | -13,83k | 317,63k | Sale to Issuer | 22,96 | 293,55k | -4,50% |
| 2025-09-02 | Mr. Gary G. CrokeSVP Product & Innovation | -6,74k | 91,09k | Derivative Exercise and Sale | 8,90 - 22,41 | 20,77k | - |
| 2025-08-28 | Mr. Gary G. CrokeSVP Product & Innovation | -181,00 | 4,21k | Sale to Issuer | 23,25 | 20,22k | -0,89% |
| 2025-08-28 | Ms. Erin R. BoaseGeneral Counsel & VP of Legal Affairs | -389,00 | 9,04k | Sale to Issuer | 23,25 | 7,03k | -5,24% |
| 2025-08-28 | Mr. Peter A. SmithPresident, CEO & Director | -4,05k | 94,21k | Sale to Issuer | 23,25 | 307,38k | -1,30% |
| 2025-07-03 | Ms. Erin R. BoaseGeneral Counsel & VP of Legal Affairs | -5,63k | 140,85k | Automatic Disposition | 25,00 | 5,83k | -49,16% |
| 2025-07-01 | Ms. Erin R. BoaseGeneral Counsel & VP of Legal Affairs | -200,00 | 5,00k | Automatic Disposition | 25,00 | 12,88k | -1,53% |
| 2025-06-24 | Ms. Erin R. BoaseGeneral Counsel & VP of Legal Affairs | -4,77k | 57,56k | Derivative Exercise and Sale | 11,00 - 23,07 | 13,08k | - |
| 2025-06-09 | Ms. Erin R. BoaseGeneral Counsel & VP of Legal Affairs | -1,17k | 14,03k | Derivative Exercise and Sale | 11,00 - 23,00 | 10,12k | - |
| 2025-06-05 | Mr. Michael C. ConnawayInsider | -2,64k | 57,24k | Sale to Issuer | 21,70 | 11,69k | -18,41% |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
